全文获取类型
收费全文 | 16421篇 |
免费 | 1536篇 |
国内免费 | 383篇 |
专业分类
耳鼻咽喉 | 48篇 |
儿科学 | 133篇 |
妇产科学 | 88篇 |
基础医学 | 855篇 |
口腔科学 | 415篇 |
临床医学 | 2483篇 |
内科学 | 2498篇 |
皮肤病学 | 165篇 |
神经病学 | 478篇 |
特种医学 | 3418篇 |
外国民族医学 | 2篇 |
外科学 | 778篇 |
综合类 | 1951篇 |
现状与发展 | 2篇 |
预防医学 | 1188篇 |
眼科学 | 717篇 |
药学 | 2138篇 |
7篇 | |
中国医学 | 302篇 |
肿瘤学 | 674篇 |
出版年
2024年 | 17篇 |
2023年 | 155篇 |
2022年 | 213篇 |
2021年 | 469篇 |
2020年 | 451篇 |
2019年 | 475篇 |
2018年 | 456篇 |
2017年 | 546篇 |
2016年 | 533篇 |
2015年 | 612篇 |
2014年 | 982篇 |
2013年 | 1119篇 |
2012年 | 1047篇 |
2011年 | 1023篇 |
2010年 | 822篇 |
2009年 | 864篇 |
2008年 | 848篇 |
2007年 | 946篇 |
2006年 | 927篇 |
2005年 | 649篇 |
2004年 | 611篇 |
2003年 | 585篇 |
2002年 | 520篇 |
2001年 | 453篇 |
2000年 | 314篇 |
1999年 | 305篇 |
1998年 | 301篇 |
1997年 | 309篇 |
1996年 | 209篇 |
1995年 | 180篇 |
1994年 | 184篇 |
1993年 | 153篇 |
1992年 | 132篇 |
1991年 | 118篇 |
1990年 | 95篇 |
1989年 | 89篇 |
1988年 | 86篇 |
1987年 | 79篇 |
1986年 | 53篇 |
1985年 | 81篇 |
1984年 | 64篇 |
1983年 | 36篇 |
1982年 | 54篇 |
1981年 | 31篇 |
1980年 | 28篇 |
1979年 | 17篇 |
1978年 | 27篇 |
1977年 | 25篇 |
1976年 | 21篇 |
1973年 | 9篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
本研究评价了喷砂、氢氟酸(HF)、氢氟酸处理后涂KH-570乙醇液等方法时国产GD光固化复合树脂以及进口VIVADENT复合树脂的修补效果.结果表明:9.6%HF处理国产树脂、喷砂处理进口树脂均获得最大的修补强度,HF KH-570处理方法虽为每种材料中之最小者,但与其它修补方法间无显著性差异. 相似文献
92.
Flecainide 总被引:1,自引:0,他引:1
RODNEY H. FALK M.D. RICHARD I. FOGEL M.D. 《Journal of cardiovascular electrophysiology》1994,5(11):964-981
Flecainide. Flecainide is a Class IC antiarrhythmic agent whose primary electrophysiologic effect is a slowing of conduction in a wide range of cardiac tissues. It is well absorbed and effective in suppressing isolated premature ventricular contractions (PVCs) or nonsustained ventricular arrhythmia but has only a modest efficacy when electrophysiologic testing is used as an endpoint. Us adverse effect on mortality in the CAST trial suggested a propensity to proarrhythmia-a phenomenon to which the Class IC agents appear particularly prone. Despite the applicability of the CAST study only to patients with a prior myocardial infarction, there has been a shift away from flecainide in ventricular arrhythmia, but the low noncardiac side effect profile of the agent allows for its continued use in a wide variety of supraventricular arrhythmias. ( J Cardiovasc Electrophysiol, Vol. 5, pp. 964–981. November 1994 ) 相似文献
93.
新螯合剂对铍中毒的解毒和促排效果 总被引:2,自引:0,他引:2
本文报道了新蟹合剂8102,S186对铍中毒动物的解毒和促排作用,并与811,DTPA 进行比较,大、小鼠BeSO_4中毒后,给予不同剂量的螯合剂解毒,结果表明,8102,S186对铍中毒动物的解毒效果均优于后两种,对大鼠的解毒作用8102优于S186,但S186对小鼠的解毒作用优于8102。螫合剂对大鼠BeSO_4染毒的排铍效果实验结果证明:各螫合剂的排铍效果强弱:8102>S186>811>DTPA。8102和S186对大鼠急性铍中毒有明显的排铍效果,若染毒前1h 或延迟4h 给药,仍有显著的排铍作用,但低于即刻用药组的效果。8102对亚急性染毒带铍状态亦有较高促排铍的作用。 相似文献
94.
95.
Respiratory symptoms associated with the use of azodicarbonamide foaming agent in a plastics injection molding facility 总被引:1,自引:0,他引:1
L W Whitehead T G Robins L J Fine D J Hansen 《American journal of industrial medicine》1987,11(1):83-92
Respiratory health variables were studied cross-sectionally in 227 employees of a plastics molding facility where numerous complaints had been apparently associated with the use of azodicarbonamide foaming agent in injection molding. Pre- and postshift respiratory status measures and azodicarbonamide concentrations were also obtained for 17 employees. Cross-sectional pulmonary function differences by injection molding status were not observed. Modest decrements in pulmonary function measures were observed between start and end of shift but with no dose-effect relationship. A strong association was observed for injection molding workers for eye/nose/throat irritation, cough, and wheezing. Additionally, wheezing, chest tightness, and symptoms of chronic bronchitis were strongly associated with work in injection molding during periods in which azodicarbonamide was in use. These results suggest respiratory symptom causation by some combination of azodicarbonamide itself, reaction products of azodicarbonamide formed during injection molding, or other unidentified agents uniquely associated with the process of injection molding with azodicarbonamide foaming agent. 相似文献
96.
Guillaume Duhamel Gottfried Schlaug David C Alsop 《Magnetic resonance in medicine》2006,55(3):514-523
Measurement of the arterial input bolus shape is essential to the quantification of mean transit time and blood flow with dynamic susceptibility contrast (DSC) MRI. Input functions derived from the echoplanar signal intensity within or near arteries are highly nonlinear, yet such input functions are widely used. We employed a physical model for the echoplanar signal intensity from an artery as a function of contrast agent concentration, artery size, and angle to the magnetic field to test approaches for the measurement of the arterial input function. The simulated results confirmed the strong nonlinearity of signal in the neighborhood of vessels. Of the input function measurement methods considered, the simulations suggested that measurement of signal near but not within a large vessel is most accurate, but mean transit times (MTT) calculated with these input functions are highly sensitive to peak bolus concentration. Input functions determined from voxels demonstrating the shortest first moment overestimated the MTT but the measured MTTs were more robust to changes in peak concentration. Characteristics of the measured in vivo input functions were consistent with the simulations. Our results emphasize the important contribution of input function errors to the uncertainty in MTT and blood flow imaging with DSC MRI. 相似文献
97.
淫羊藿总黄酮对肾上腺素β_1受体的特异性阻断作用 总被引:2,自引:0,他引:2
为探讨淫羊藿总黄酮(TFE)对肾上腺素受体的作用,本实验用离体兔心房肌、主动脉及豚鼠气管观察了TFE对肾上腺素全体的作用,结果TFE(0.13g/L)抑制心房肌肌力和频率,并使异丙肾上腺素(ISO)对心房肌正性频率作用的量效曲线平行右移,但无钙拮抗作用及M受体激动效应,且不影响ISO对豚鼠气管条的负性肌力作用及去甲肾上腺囊(NE)对兔主动脉条的收缩作用。提示TFE选择性阻断肾上腺素β_1受体。 相似文献
98.
观察了30例伴有高脂血症的Ⅱ型糖尿病患者用小剂量乐脂平(500mg/d)治疗4周后血清脂质、脂蛋白的变化。结果:血总胆固醇、甘油三酯及极低密度脂蛋白—胆固醇水平较治疗前下降,高密度脂蛋白—胆固醇明显升高,血糖、血肌酐及血尿酸无明显变化。服用该药未观察到不良反应,提示乐脂平能较好地改善糖尿病患者的脂代谢紊乱。 相似文献
99.
Maythem Saeed Michael F. Wendland Takayuki Masui Charles B. Higgins 《Magnetic resonance in medicine》1994,31(1):31-39
The purpose of this study was to characterize the contrast caused by a susceptibility MRI contrast agents, on spin echo T2-weighted imaging of reperfused myocardial infarction. Our interest in this model focused on the expected requirement that such agents be compartmentalized in the tissue to cause signal loss on spin echo images, a condition which may not be present in reperfused infarcted myocardium. Accordingly, nine rats were subjected to 2 h of left coronary artery occlusion followed by 3 ± 0.5 h of reperfusion prior to administration of contrast media. Three sets of MR images were acquired: (a) baseline axial images at the midventricle, both T1-weighted (TR/TE = 300/20) and T2-weighted (TR/TE = 1500/60); (b) T1-weighted images after administering a T1-enhancing agent, Gd-DTPA-BMA (0.2 mmol/kg), to document that contrast media is delivered to the reperfused infarction; and (c) T2-weighted images after administering the susceptibility agent, Dy-DTPA-BMA (1.0 mmol/kg). Gadolinium-enhanced T1 images depicted reperfused infarction as regions with greatly enhanced signal intensity compared with unin-farcted myocardium, indicating that contrast agent was delivered to the infarcted zone. Dysprosium-enhanced T1 images depicted the injury as a region of persistent signal intensity relative to depletion of signal in normal myocardium, consistent with failure of the contrast agent to cause signal loss. Similar infarction sizes were observed for unenhanced T2-weighted images (33 ± 5%), gadolinium-enhanced T1 weighted images (36 ± 5%) and postmortem staining (30 ± 6%); strong correlations (r > 0.9) were noted in comparisons of these data. Dysprosium-enhanced images exhibited a smaller region of differential signal presumed to be infarction (20 ± 5%, P < 0.05) and weak correlations (r < 0.75) with the other measurements. We conclude that the smaller infarction depicted on dysprosium-enhanced images is a subregion of the true infarction in which myocardial necrosis is sufficiently advanced that the agent is homogeneously distributed throughout all tissue compartments, preventing T2*-dependent phase loss on spin echo images. 相似文献
100.
Karl Hittmair Gregor Gomiscek Karl Langenberger Michael Recht Herwig Imhof Josef Kramer 《Magnetic resonance in medicine》1994,31(5):567-571
In previous papers relative signal intensity increase was used as a quantitative assessment parameter for contrast uptake in contrastenhanced MRI. However, relative signal intensity increase does not only reflect contrast uptake but depends also on tissue parameters (native T1 relaxation time) and sequence parameters (repetition time and flip angle); thus, the contrast uptake cannot be assessed accurately using relative signal intensity increase. Based on an analysis of the contrast behavior of spoiled gradient echo sequences, a method is described in this paper that overcomes the limitations of relative signal intensity increase measurement. A parameter, called “enhancement factor” (EF) is introduced that approximates differential T1 relaxation rate. The enhancement factor scales linearly with contrast uptake and is independent of tissue and sequence parameters. The additional measurement time involved in determining the enhancement factor is less than 1 min and computation is straightforward. The practicality of the new method was confirmed by phantom measurements using T1-weighted and proton density-weighted spoiled gradient echo sequences (FLASH-2D). Enhancing tissues were simulated by water phantoms doped with increasing concentrations of Gd-DTPA. 相似文献